Novel simplified yeast-based assays of regulators of p53-MDMX interaction and p53 transcriptional activity
Open Access
- 1 October 2013
- journal article
- research article
- Published by Wiley in The FEBS Journal
- Vol. 280 (24) , 6498-6507
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- MDM2, MDMX and p53 in oncogenesis and cancer therapyNature Reviews Cancer, 2013
- On the Mechanism of Action of SJ-172550 in Inhibiting the Interaction of MDM4 and p53PLOS ONE, 2012
- p53 Transactivation and the Impact of Mutations, Cofactors and Small Molecules Using a Simplified Yeast-Based Screening SystemPLOS ONE, 2011
- Distinct regulation of p53-mediated apoptosis by protein kinase Cα, δ, ε and ζ: Evidence in yeast for transcription-dependent and -independent p53 apoptotic mechanismsExperimental Cell Research, 2011
- Identification and Characterization of the First Small Molecule Inhibitor of MDMXJournal of Biological Chemistry, 2010
- Targeting Mdm2 and Mdmx in Cancer Therapy: Better Living through Medicinal Chemistry?Molecular Cancer Research, 2009
- Actin Bodies in Yeast Quiescent Cells: An Immediately Available Actin Reserve?Molecular Biology of the Cell, 2006
- p53 Activation by Small Molecules: Application in OncologyJournal of Medicinal Chemistry, 2005
- Prospective therapeutic applications of p53 inhibitorsBiochemical and Biophysical Research Communications, 2005
- Novel human p53 mutations that are toxic to yeast can enhance transactivation of specific promoters and reactivate tumor p53 mutantsOncogene, 2001